Maravai LifeSciences Holdings Inc. (MRVI) Fundamentals

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company's segments are Nucleic acid production, Biologics safety testing, and Protein detection. It generates a majority of its revenue from the Nucleic Acid Production that focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
SHARE INFORMATION
Market Cap$ 1,874,439,899
Shares Outstanding131,539,642
Float89,146,271
Percent Float67.77%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 799,240,000
Latest Fiscal EPS$ 1.55
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions562
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months16,007,638
Institutional Holdings Percent172.1%
Institutional Sold Previous 3 Months26,160,216
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months992,039
Insider Holdings Percent0.6
Insider Sold Previous 3 Months-
Insider Shares Owned809,551
TRADING INFO
52 Week High$ 46.29
52 Week Low$ 13.41
52 Week High Change$ -60.95
21 Day Moving Average$ 15.0805
21 Day Extended Moving Average$ 15.3639
50 Day Moving Average$ 18.7277
50 Day Extended Moving Average$ 17.8867
200 Day Moving Average$ 27.5366
200 Day Extended Moving Average$ 25.8166
10 Day Average Volume2,533,452
20 Day Average Volume2,379,711
30 Day Average Volume2,173,998
50 Day Average Volume2,304,378
Alpha-0.005174
Beta-0.2374
Standard Deviation0.184819
R20.004666
7 Day Price Change$ -0.10
7 Day Percent Change-0.7%
21 Day Price Change$ -1.11
21 Day Percent Change-7.23%
30 Day Price Change$ -2.43
30 Day Percent Change-14.57%
Month to Date Price Change$ -2.35
Month to Date Percent Change-14.16%
Quarter to Date Price Change$ -11.28
Quarter to Date Percent Change-44.18%
180 Day Price Change$ -21.44
180 Day Percent Change-60.07%
200 Day Price Change$ -18.12
200 Day Percent Change-55.98%
Year to Date Price Change$ -27.65
Year to Date Percent Change-65.99%

Maravai LifeSciences Holdings Inc. (MRVI) Key Ratios

PROFITABILITY
EBIT Margin68.1%
EBITDA Margin71.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count58.44%
Gross Margin82.9%
Profit Margin TOT58.44%
INCOME STATEMENTS
Revenue$ 906,732,000
Revenue Per Share$ 6.8932
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-706.20
Total Debt To Equity1.10
Int Coverage35.80
Current Ratio7.20
Leverage Ratio5.00
Quick Ratio6.50
Long Term Debt To Capital0.51
VALUATION MEASURES
PE Ratio8.00
Enterprise Value$ 1,804,244,862
Price to Sales2.0672
Price to Free Cash7.90
PE High Last 5 Years0.00
Price To Book3.80
Price To Cash Flow7.40
PE Low Last 5 Years0.00
Price to Tangible Book-706.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover9.70
Invoice Turnover2.80
Assets Turnover0.50
Return Assets12.37
Return on Equity62.73
Return on Capital26.32

Maravai LifeSciences Holdings Inc. (MRVI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOCarl W. Hull / William Martin
Emplyoees550
Last AuditUE
CIK0001823239
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address10770 Wateridge Circle
Suite 200
San Diego, CA 92121
Websitehttps://www.maravai.com
Facsimile-
Telephone+1 858 546-0004
Emaildavid.weber@maravai.com


Your Recent History
NASDAQ
MRVI
Maravai Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.